Evolution of HER2 expression between pre-treatment biopsy and residual disease after neoadjuvant therapy for breast cancer
Paolo Tarantino, Ogheneochuko Ajari, Noah Graham, Julie Vincuilla, Tonia Parker, Melissa E. Hughes, Nabihah Tayob, Ana C. Garrido-Castro, Stefania Morganti, Tari A. King, Elizabeth A. Mittendorf, Giuseppe Curigliano, Nancy U. Lin, Sara M. Tolaney
Topics & Concepts
Breast cancerMedicineNeoadjuvant therapyBiopsyOncologyMinimal residual diseaseDiseaseResidualCancerInternal medicineCancer researchAlgorithmComputer scienceLeukemiaHER2/EGFR in Cancer ResearchBreast Cancer Treatment StudiesAdvanced Breast Cancer Therapies